» Articles » PMID: 12628004

The Human Neuroendocrine Thyrotropin-releasing Hormone Receptor Promoter is Activated by the Haematopoietic Transcription Factor C-Myb

Overview
Journal Biochem J
Specialty Biochemistry
Date 2003 Mar 12
PMID 12628004
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Thyrotropin-releasing hormone (TRH) receptor (TRHR) is a G-protein-coupled receptor playing a crucial role in the anterior pituitary where it controls the synthesis and secretion of thyroid-stimulating hormone and prolactin. Its widespread presence not only in the central nervous system, but also in peripheral tissues, including thymus, indicates other important, but unknown, functions. One hypothesis is that the neuropeptide TRH could play a role in the immune system. We report here that the human TRHR promoter contains 11 putative response elements for the haematopoietic transcription factor c-Myb and is highly Myb-responsive in transfection assays. Analysis of Myb binding to putative response elements revealed one preferred binding site in intron 1 of the receptor gene. Transfection studies of promoter deletions confirmed that this high-affinity element is necessary for efficient Myb-dependent transactivation of reporter plasmids in CV-1 cells. The Myb-dependent activation of the TRHR promoter was strongly suppressed by expression of a dominant negative Myb-Engrailed fusion. In line with these observations, reverse transcriptase PCR analysis of rat tissues showed that the TRHR gene is expressed both in thymocytes and bone marrow. Furthermore, specific, high-affinity TRH agonist binding to cell-surface receptors was demonstrated in thymocytes and a haematopoietic cell line. Our findings imply a novel functional link between the neuroendocrine and the immune systems at the level of promoter regulation.

Citing Articles

The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?.

Charli J, Rodriguez-Rodriguez A, Hernandez-Ortega K, Cote-Velez A, Uribe R, Jaimes-Hoy L Front Pharmacol. 2020; 11:640.

PMID: 32457627 PMC: 7225337. DOI: 10.3389/fphar.2020.00640.


The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

Garcia M, Barrio R, Garcia-Lavandeira M, Garcia-Rendueles A, Escudero A, Diaz-Rodriguez E Sci Rep. 2017; 7:42937.

PMID: 28262687 PMC: 5338029. DOI: 10.1038/srep42937.


Hormonal control of T-cell development in health and disease.

Savino W, Mendes-da-Cruz D, Lepletier A, Dardenne M Nat Rev Endocrinol. 2015; 12(2):77-89.

PMID: 26437623 DOI: 10.1038/nrendo.2015.168.


Hypothalamic neurohormones and immune responses.

Quintanar J, Guzman-Soto I Front Integr Neurosci. 2013; 7:56.

PMID: 23964208 PMC: 3741963. DOI: 10.3389/fnint.2013.00056.

References
1.
Thompson M, Ramsay R . Myb: an old oncoprotein with new roles. Bioessays. 1995; 17(4):341-50. DOI: 10.1002/bies.950170410. View

2.
Andersson K, Berge T, Matre V, Gabrielsen O . Sequence selectivity of c-Myb in vivo. Resolution of a DNA target specificity paradox. J Biol Chem. 1999; 274(31):21986-94. DOI: 10.1074/jbc.274.31.21986. View

3.
Naper C, Vaage J, Lambracht D, Lovik G, Butcher G, Wonigeit K . Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control. Eur J Immunol. 1995; 25(5):1249-56. DOI: 10.1002/eji.1830250518. View

4.
OLeary R, OConnor B . Thyrotropin-releasing hormone. J Neurochem. 1995; 65(3):953-63. DOI: 10.1046/j.1471-4159.1995.65030953.x. View

5.
Fukusumi S, Ogi K, Onda H, Hinuma S . Distribution of thyrotropin-releasing hormone receptor mRNA in rat peripheral tissues. Regul Pept. 1995; 57(2):115-21. DOI: 10.1016/0167-0115(95)00026-8. View